Zobrazeno 81 - 90
of 254
pro vyhledávání: '"Charles E. Geyer"'
Autor:
Thomas J. Saphner, George W. Sledge, Jeffrey Abrams, Maccon M. Keane, Timothy F. Goggins, John A. Olson, Virginia G. Kaklamani, Kathy S. Albain, Adam Brufsky, Peter M. Ravdin, Charles E. Geyer, Soonmyung Paik, Matthew J. Ellis, Ingrid A. Mayer, Lynne I. Wagner, Sunil Badve, Robert Gray, Henry L. Gomez Moreno, Pavan S. Reddy, Elizabeth Claire Dees, Joseph A. Sparano, Daniel F. Hayes, Deborah Toppmeyer, Tracy Lively, Kathleen I. Pritchard, Della F. Makower, Timothy J. Whelan, Jeffery L. Berenberg, William C. Wood, Matthew P. Goetz
Publikováno v:
The New England journal of medicine. 379(2)
The recurrence score based on the 21-gene breast cancer assay predicts chemotherapy benefit if it is high and a low risk of recurrence in the absence of chemotherapy if it is low; however, there is uncertainty about the benefit of chemotherapy for mo
Autor:
Sandra M. Swain, James L. Wade, Stephen Chia, Charles E. Geyer, Louis Fehrenbacher, Janice M. Walshe, Gamini S. Soori, Eleftherios P. Mamounas, Hanna Bandos, D. Lawrence Wickerham, Jong-Hyeon Jeong, Soonmyung Paik, Edward C. McCarron, Mark L. Graham, Shaker R. Dakhil, Adam Brufsky, Priya Rastogi, Barry C. Lembersky, Norman Wolmark, Thomas E. Seay
Publikováno v:
The Lancet. Oncology. 20(1)
The optimal duration of extended therapy with aromatase inhibitors in patients with postmenopausal breast cancer is unknown. In the NSABP B-42 study, we aimed to determine whether extended letrozole treatment improves disease-free survival after 5 ye
Autor:
J Huober, Sabine Seiler, G. von Minckwitz, S. Loibl, Michael Untch, J-U Blohmer, Claus Hanusch, Joseph P. Costantino, Norman Wolmark, Valentina Nekljudova, K Rhiem, C. Jackisch, Priya Rastogi, Charles E. Geyer, Andreas Schneeweiss, PA Fasching, Carsten Denkert
Publikováno v:
Senologie - Zeitschrift für Mammadiagnostik und -therapie.
Autor:
Stephanie M. Wong, Mehra Golshan, O. Metzger-Filho, Danielle Sullivan, Norman Wolmark, Joyce O'Shaughnessy, Michael Untch, Charles E. Geyer, J Huober, David Maag, G. von Minckwitz, Mark D. McKee, Hope S. Rugo, S. Loibl, William M. Sikov
Publikováno v:
European Journal of Surgical Oncology. 45:e12-e13
Autor:
W. Fraser Symmans, Mehra Golshan, Kristi McIntyre, Mark D. McKee, David Maag, Sibylle Loibl, Michael Untch, Charles E. Geyer, Joyce O'Shaughnessy, Otto Metzger Filho, Danielle Sullivan, Hope S. Rugo, Gunter von Minckwitz, Jose Juan Ponce Lorenzo, William M. Sikov, Jens Huober, Xuan Liu, Priya Rastogi, Norman Wolmark
Publikováno v:
LANCET ONCOLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Background Although several randomised trials in patients with triple-negative breast cancer have shown that the addition of carboplatin, with or without poly(ADP-ribose) polymerase (PARP) inhibitors, to neoadjuvant chemotherapy increases the likelih
Autor:
James N. Ingle, Charles E. Geyer, Herve R Bonnefoi, Meritxell Bellet, Babara A Walley, HJ Burstein, Miguel Angel Climent, Stefan Buchholz, Gini F. Fleming, Silvana Martino, Manuela Rabaglio-Poretti, István Láng, Robert E. Coleman, Meredith M. Regan, Pierre Kerbrat, E.M. Ciruelos, Marco Colleoni, Lorenzo Pavesi, PA Francis, Nancy E Davidson
Publikováno v:
Cancer Research. 75:S3-08
Background It is uncertain if the addition of OFS to adjuvant endocrine therapy with T improves outcomes in premenopausal HR+ BC. The SOFT trial was designed to determine the value of OFS in women who remain premenopausal and are treated with T (OFS
Autor:
Gong Tang, Qing Liu, Thomas B. Julian, Eleftherios P. Mamounas, Joseph P. Costantino, Charles E. Geyer, Sandra M. Swain, Priya Rastogi, Jong-Heyon Jeong, Norman Wolmark, Soonmyung Paik, D. Lawrence Wickerham
Publikováno v:
Cancer Research. 75:P5-21
Background Adjuvant systemic therapy reduces risk of distant recurrence (DR) and breast cancer death. In addition, adjuvant systemic therapy reduces risk of loco-regional recurrence (LRR). We examined the magnitude of the effect of adjuvant systemic
Autor:
Jong-Hyeon Jeong, Joseph P. Costantino, Melanie Finnigan, Sandra M. Swain, Priya Rastogi, Charles E. Geyer, Nan Song, D. Lawrence Wickerham, Patrick G. Gavin, Norman Wolmark, Seong Rim Kim, Eleftherios P. Mamounas, Katherine L. Pogue-Geile, Louis Fehrenbacher, Nicole L. Blackmon, Soonmyung Paik
Publikováno v:
Journal of Clinical Oncology. 33:1340-1347
Purpose Considerable molecular heterogeneity exists among human epidermal growth factor receptor 2 (HER2) –positive breast cancer regarding gene expression and mutation profiling. Evidence from preclinical, clinical neoadjuvant, and metastatic clin
Autor:
Charles E. Geyer, Patricia Cortazar
Publikováno v:
Annals of Surgical Oncology. 22:1441-1446
There has been recent interest in using pathological complete response (pCR) as a potential surrogate endpoint for long-term outcomes in the neoadjuvant treatment of high-risk, early-stage breast cancer. We review the clinical trials that have contri
Autor:
Charles E. Geyer
Publikováno v:
Breast Diseases: A Year Book Quarterly. 26:113-117
Historically, locoregional recurrence (LRR) of breast cancer comprised the recurrence of breast cancer following mastectomy occurring in the skin of the chest wall, the surgical scar, the axilla, or in other regional lymph nodes such as the ipsilater